RID-F
RID-F (Ridaifen-F), a Tamoxifen derivative, is a nonpeptidic proteasome inhibitor. RID-F inhibits human 20S proteasome activity, with IC50s of 0.64, 0.34, and 0.43 μM for CT-L, T-L, and PGPH, respectively[1].
Product Specifications
CAS Number
1020853-03-5
Product Name Alternative
Ridaifen-F
UNSPSC
12352005
Target
Proteasome
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rid-f.html
Solubility
10 mM in DMSO
Smiles
CC/C(C1=CC=CC=C1)=C(C2=CC=C(OCCN3CCCCCC3)C=C2)\C4=CC=C(OCCN5CCCCCC5)C=C4
Molecular Formula
C38H50N2O2
Molecular Weight
566.82
References & Citations
[1]Hasegawa M, et, al. A novel tamoxifen derivative, ridaifen-F, is a nonpeptidic small-molecule proteasome inhibitor. Eur J Med Chem. 2014 Jan:71:290-305.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY423285 100 µg
TRAPPC2 (NM_001011658) Human Over-expression Lysate
Sign In for Pricing
View Details 
